An aerosol like this still has a number of ways to reach the public. Human clinical trials will be required, not to mention large-scale production to provide adequate accessibility. Scientists are planning to “go fast” to further testing, Columbia said.
This move could provide protection in parts of the world where mass vaccination of COVID-19 would be difficult. It could also act as a “supplement” even where vaccines are available, said lead researchers Anne Moscona and Matteo Porotto. People who cannot vaccinate or who cannot get vaccinated, can spray themselves daily knowing they will be safe. Therefore, that could further limit the spread of the virus and accelerate the end of a pandemic.